Delivery Order SPE2DR25D2104-SPE2DR26F3QQV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,733.84 to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, an oral antibiotic commonly prescribed for bacterial infections. The contract, awarded April 30, 2025, with completion by May 1, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,939.11 to AmerisourceBergen Drug Corp for the supply of Cefdinir 300 mg capsules (60-count units) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Cefdinir is a third-generation cephalosporin antibiotic commonly used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, a broad-spectrum antibiotic commonly used for bacterial infections in military and veteran healthcare settings. This $1,103.02 firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,555.75 to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, a commonly prescribed oral antibiotic. The contract is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and was awarded on August 2, 2025. No set-aside designation was used for this competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) under a firm fixed-price contract with a ceiling value of $1,141.79. This non-set-aside award represents a competitive delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026. The ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cefdinir 300 mg capsules (60-count units) under a firm fixed price contract valued at $2,574.49. The award, made on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) with a ceiling value of $7,070.12. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $2,331.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cefdinir 300 mg capsules (60-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $4,757.15 to AmerisourceBergen Drug Corp for the supply of Cefdinir 300mg capsules (60-count) on September 12, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with the Defense Logistics Agency Troop Support Medical, a $999.99 billion comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Cefdinir 300 mg capsules (60-count) at a ceiling value of $1,347.10. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 10, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3QQVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,185.96 to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, an oral antibiotic commonly used to treat bacterial infections across military and federal healthcare systems. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as one of the nation's largest pharmaceutical distributors serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency. The company's federal contract portfolio demonstrates consistent capability to fulfill competitive federal medical supply requirements across multiple therapeutic domains and order values, from small transactions to substantial procurements exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/3/25 |